Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert review
Authors:
- Paolo A. AsciertoPAPaolo A. Ascierto
- Helen J. GogasHGHelen J. Gogas
- Jean Jacques GrobJGJean Jacques Grob
- Salvador Martín AlgarraSASalvador Martín Algarra
- Peter MohrPMPeter Mohr
- Johan HanssonJHJohan Hansson
- Axel HauschildAHAxel Hauschild
- 1 February 2013
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 85 (2) , 149-161
Abstract
No abstract availableKeywords
Funding Information
- Merck & Co. Inc
This publication has 56 references indexed in Scilit:
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patientsJournal of Translational Medicine, 2011
- Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trialThe Lancet Oncology, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatmentJournal of Translational Medicine, 2010
- Correlation of molecular human leukocyte antigen typing and outcome in high‐risk melanoma patients receiving adjuvant interferonCancer, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Prognostic Significance of Serum S100B Protein in High-Risk Surgically Resected Melanoma Patients Participating in Intergroup Trial ECOG 1694Journal of Clinical Oncology, 2009
- Adjuvant therapy of melanoma with interferon: lessons of the past decadeJournal of Translational Medicine, 2008
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in ScandinaviaInternational Journal of Cancer, 2003